Reimbursed with a limitationOriginator productATC N05AE05

Latuda

Latuda is an originator product from Medius AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 103.90 to CHF 252.40 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Medius AG
ATC code
N05AE05
IT group
01.05 Neuroleptica
Active substances
Lurasidoni hydrochloridum
Preparation type
Originator product
On the SL since
01/09/2013
Last price change
01/02/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Latuda Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 20 mgBlist 28 StkCHF 80.42CHF 103.9001/11/2020B7680627850078
Filmtabl 20 mgBlist 56 StkCHF 160.85CHF 191.3501/08/2021B7680627850085
Filmtabl 40 mg28 StkCHF 80.42CHF 103.9001/09/2013B7680627850016
Filmtabl 40 mg56 StkCHF 160.85CHF 191.3501/09/2013B7680627850023
Filmtabl 80 mg28 StkCHF 108.49CHF 134.4001/09/2013B7680627850030
Filmtabl 80 mg56 StkCHF 216.99CHF 252.4001/09/2013B7680627850047

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 20064.01Valid from 01/04/2021

Die Vergütung der einzelnen Dosisstärken erfolgt entsprechend der Zulassung indikationsabhängig gemäss Fachinformation:
Schizophrenie: Latuda 40 mg und Latuda 80 mg
Behandlung depressiver Episoden im Rahmen einer bipolaren Störung Typ 1: Latuda 20 mg und Latuda 40 mg

Entstehen für die Behandlung depressiver Episoden im Rahmen einer bipolaren Störung Typ 1 aufgrund einer Dosisanpassung auf 60 mg (20 mg + 40 mg) die doppelten Kosten, sind die Kosten der jeweiligen Packungen Latuda 20 mg auf Basis FAP von der Medius AG demjenigen Krankenversicherer rückzuvergüten, bei dem die versicherte Person zum Zeitpunkt des Bezuges versichert war. Die MWSt kann nicht zusätzlich zum FAP zurückgefordert werden. Der Krankenversicherer fordert die Firma Medius AG zur Rückvergütung auf. Die Aufforderung zur Rückvergütung soll in der Regel innerhalb von drei Monaten nach Beendigung der Therapie erfolgen.

FAQ

Is Latuda covered by Swiss health insurance?

Yes, but only under conditions. Latuda is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Latuda cost in Switzerland?

The public price is the maximum price set by the FOPH and for Latuda ranges from CHF 103.90 to CHF 252.40 per pack. The ex-factory price ranges from CHF 80.42 to CHF 216.99. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com